These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
931 related articles for article (PubMed ID: 18852227)
1. Greater accrual damage in late-onset systemic lupus erythematosus: a long-term follow-up study. Appenzeller S; Pereira DA; Costallat LT Lupus; 2008 Nov; 17(11):1023-8. PubMed ID: 18852227 [TBL] [Abstract][Full Text] [Related]
2. Systemic lupus erythematosus in a multiethnic US cohort. XXXIII. Clinical [corrected] features, course, and outcome in patients with late-onset disease. Bertoli AM; Alarcón GS; Calvo-Alén J; Fernández M; Vilá LM; Reveille JD; Arthritis Rheum; 2006 May; 54(5):1580-7. PubMed ID: 16645994 [TBL] [Abstract][Full Text] [Related]
3. The rate and pattern of organ damage in late onset systemic lupus erythematosus. Maddison P; Farewell V; Isenberg D; Aranow C; Bae SC; Barr S; Buyon J; Fortin P; Ginzler E; Gladman D; Hanly J; Manzi S; Nived O; Petri M; Ramsey-Goldman R; Sturfelt G; J Rheumatol; 2002 May; 29(5):913-7. PubMed ID: 12022349 [TBL] [Abstract][Full Text] [Related]
4. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Brunner HI; Gladman DD; Ibañez D; Urowitz MD; Silverman ED Arthritis Rheum; 2008 Feb; 58(2):556-62. PubMed ID: 18240232 [TBL] [Abstract][Full Text] [Related]
5. High predictive value of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for survival in systemic lupus erythematosus. Nived O; Jönsen A; Bengtsson AA; Bengtsson C; Sturfelt G J Rheumatol; 2002 Jul; 29(7):1398-400. PubMed ID: 12136895 [TBL] [Abstract][Full Text] [Related]
6. The effect of menopause on disease activity in systemic lupus erythematosus. Urowitz MB; Ibañez D; Jerome D; Gladman DD J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295 [TBL] [Abstract][Full Text] [Related]
7. Clinical features and prognosis of late-onset systemic lupus erythematosus: results from the 1000 faces of lupus study. Lalani S; Pope J; de Leon F; Peschken C; J Rheumatol; 2010 Jan; 37(1):38-44. PubMed ID: 20008925 [TBL] [Abstract][Full Text] [Related]
8. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study. Mok CC; Ho LY; Cheung MY; Yu KL; To CH Scand J Rheumatol; 2009; 38(2):121-7. PubMed ID: 18991189 [TBL] [Abstract][Full Text] [Related]
9. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women. Fernández M; Calvo-Alén J; Alarcón GS; Roseman JM; Bastian HM; Fessler BJ; McGwin G; Vilá LM; Sanchez ML; Reveille JD Arthritis Rheum; 2005 Jun; 52(6):1655-64. PubMed ID: 15934092 [TBL] [Abstract][Full Text] [Related]
10. Clinical and laboratory characteristics and long-term outcome of pediatric systemic lupus erythematosus: a longitudinal study. Hiraki LT; Benseler SM; Tyrrell PN; Hebert D; Harvey E; Silverman ED J Pediatr; 2008 Apr; 152(4):550-6. PubMed ID: 18346514 [TBL] [Abstract][Full Text] [Related]
11. Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations. Vilá LM; Alarcón GS; McGwin G; Friedman AW; Baethge BA; Bastian HM; Fessler BJ; Reveille JD; Rheumatology (Oxford); 2004 Mar; 43(3):358-63. PubMed ID: 14623949 [TBL] [Abstract][Full Text] [Related]
12. Clinical and serologic factors associated with lupus pleuritis. Mittoo S; Gelber AC; Hitchon CA; Silverman ED; Pope JE; Fortin PR; Pineau C; Smith CD; Arbillaga H; Gladman DD; Urowitz MB; Zummer M; Clarke AE; Bernatsky S; Hudson M; Tucker LB; Petty RE; ; Peschken CA J Rheumatol; 2010 Apr; 37(4):747-53. PubMed ID: 20110526 [TBL] [Abstract][Full Text] [Related]
14. Long-term outcome of early neuropsychiatric events due to active disease in systemic lupus erythematosus. Wang M; Gladman DD; Ibañez D; Urowitz MB Arthritis Care Res (Hoboken); 2012 Jun; 64(6):833-7. PubMed ID: 22290935 [TBL] [Abstract][Full Text] [Related]
15. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Mikdashi J; Handwerger B Rheumatology (Oxford); 2004 Dec; 43(12):1555-60. PubMed ID: 15342927 [TBL] [Abstract][Full Text] [Related]
16. Predictors of damage progression in Portuguese patients with systemic lupus erythematosus. Santos MJ; Vinagre F; Nero P; Barcelos F; Barcelos A; Rodrigues AM; de Matos AA; Silva C; Miranda L; Capela S; Marques A; Branco J; da Silva JC Ann N Y Acad Sci; 2009 Sep; 1173():822-8. PubMed ID: 19758234 [TBL] [Abstract][Full Text] [Related]
17. Damage accumulation in systemic lupus erythematosus and its relation to disease activity and mortality. Becker-Merok A; Nossent HC J Rheumatol; 2006 Aug; 33(8):1570-7. PubMed ID: 16845708 [TBL] [Abstract][Full Text] [Related]
18. Late onset lupus: a clinical and immunological study in a predominantly Chinese population. Koh ET; Boey ML J Rheumatol; 1994 Aug; 21(8):1463-7. PubMed ID: 7983647 [TBL] [Abstract][Full Text] [Related]
19. Accrual of organ damage over time in patients with systemic lupus erythematosus. Gladman DD; Urowitz MB; Rahman P; Ibañez D; Tam LS J Rheumatol; 2003 Sep; 30(9):1955-9. PubMed ID: 12966597 [TBL] [Abstract][Full Text] [Related]
20. Effect of severe neuropsychiatric manifestations on short-term damage in systemic lupus erythematosus. Fragoso-Loyo HE; Sánchez-Guerrero J J Rheumatol; 2007 Jan; 34(1):76-80. PubMed ID: 17143970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]